Wells Doesn't See Cell Therapeutics' (CTIC) Pacritinib as Threat to Incyte's (INCY) Jakafi
Tweet Send to a Friend
Incyte (Nasdaq: INCY) is lower Monday amid positive comments out of Wells Fargo with respect to segment competition.
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
